Finance Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Finance Industry Today.

Press releases published on June 14, 2026

5 hours ago

Miami Mortgage Broker Philip Bennett Explains How Foreign Nationals Can Finance Florida Real Estate Without U.S. Credit

Indeterminate EIN Presswire

5 hours ago

Miles Alexander III Launches ‘Mr. Miles World of Dreams’ Children’s Book Series to Inspire Young Readers

Indeterminate EIN Presswire

6 hours ago

Z-Text Bug Bounty Goes Live: 7 ZEC On-Chain to Anyone Who Breaks It

Indeterminate EIN Presswire

an hour ago

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

2 hours ago

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Indeterminate GlobeNewswire

3 hours ago

Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Indeterminate GlobeNewswire

16 hours ago

RISE OF CONCIERGE SERVICES TRANSFORMS LUXURY LIVING IN QUEENSLAND, AUSTRALIA

Indeterminate EIN Presswire

4 hours ago

Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02

Indeterminate GlobeNewswire

5 hours ago

MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win

Indeterminate GlobeNewswire

5 hours ago

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

6 hours ago

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

7 hours ago

ディファイアンスETFs、シーボーBZX取引所におけるディファイアンス・デイリー2XスペースETF (SPCL) の一時取引停止を発表

Indeterminate GlobeNewswire

7 hours ago

스페이스X 2배 레버리지 ETF (SPCL), Cboe BZX 거래소 조치로 거래 일시 중지했다고 Defiance ETFs가 발표

Indeterminate GlobeNewswire

7 hours ago

Defiance ETFs Umumkan Penggantungan Sementara Dagangan Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc.

Indeterminate GlobeNewswire

7 hours ago

Defiance ETFs 宣布 Defiance Daily 2X Space ETF (SPCL) 在 Cboe BZX Exchange, Inc. 暂停交易

Indeterminate GlobeNewswire

7 hours ago

Defiance ETFs 宣佈，Defiance Daily 2X Space ETF (SPCL) 暫時停止於 Cboe BZX Exchange, Inc. 進行交易

Indeterminate GlobeNewswire

8 hours ago

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Indeterminate GlobeNewswire

10 hours ago

Salomon Unfolds the Next Chapter of ROAD TO THE FUTURE in Shanghai

Indeterminate GlobeNewswire

14 hours ago

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL

Indeterminate GlobeNewswire